Difference between revisions of "Team:KU Leuven/Future"

Line 107: Line 107:
 
<p>
 
<p>
  
The knowledge transfer from pure scientific research to the commercial environment is a major challenge to tackle for both academics and industry. By analyzing the future potential of our project, we explore how its scientific contribution could be useful for companies in different industries. The focus lies mainly on the development of artificial bone implants, where the economic rationale for further investments is analyzed combined with a brief description of possible barriers for its future. Other applications for the biomaterial and medical industry as well as others are also described. On top of that we explain how a future collaboration with the TU Delft iGEM team could be beneficial for the both of us.  
+
The knowledge transfer from pure scientific research to the commercial environment is a major challenge to tackle for both academia and industry. By analyzing the future potential of our project, we explore how its scientific contribution could be useful for different industries. The focus lies mainly on the development of artificial bone implants, where the economic rationale for further investments is analyzed combined with a brief description of possible barriers for its future. Other applications for the biomaterial and medical industry are described as well. On top of that, we explain how a future collaboration with the TU Delft iGEM team could be beneficial for the both of us.  
  
 
</p>
 
</p>

Revision as of 02:18, 19 September 2015

Logo

Future potential of Spot E.Shape

Twitter
mail
mail

The knowledge transfer from pure scientific research to the commercial environment is a major challenge to tackle for both academia and industry. By analyzing the future potential of our project, we explore how its scientific contribution could be useful for different industries. The focus lies mainly on the development of artificial bone implants, where the economic rationale for further investments is analyzed combined with a brief description of possible barriers for its future. Other applications for the biomaterial and medical industry are described as well. On top of that, we explain how a future collaboration with the TU Delft iGEM team could be beneficial for the both of us.





Contact

Address: Celestijnenlaan 200G room 00.08 - 3001 Heverlee
Telephone: +32(0)16 32 73 19
Email: igem@chem.kuleuven.be